The Next Generation of Medication
Nextgen Pharmaceuticals, LLC, based in New York, was established in July 2015 and is an emerging pharmaceutical company. Together with its strategic partners, Nextgen is collaboratively developing a portfolio of prescription products in various dosage forms covering a broad range of therapeutic categories.
With a primary focus on Oncology and Immuno-suppressant medication, Nextgen currently has 2 products with FDA approval and a pipeline of over 15 more subject to FDA approval. In addition, Nextgen continues to pursue licensing opportunities to complement its expanding portfolio.